Cooperative Agreement 2437512

Award Date 7/15/25
Completion Date 6/30/27
Dollars Obligated $1.2M
Federal Grant Program
47.084
Assistance Type
Cooperative Agreement
Place of Performance
Putney, VT 05346, USA
Similar Awards
CPR Therapeutics Inc. received a $512,000 National Science Foundation Project Grant award under the NSF Technology, Innovation, and Partnerships program to develop an automated multimodal cardiopulmonary resuscitation system. The one-year award will support preclinical research and optimization studies using a swine model of cardiac arrest to design a next-generation proof-of-concept prototype. The system aims to improve outcomes for sudden cardiac arrest patients by integrating multiple...
This Project Grant from the National Science Foundation's Division of Industrial Innovation, under the Engineering program (CFDA 47.041), provides $256,000 to Colabs, Inc. to develop an automated airway and ventilator system that eliminates human operator variability during cardiopulmonary resuscitation (CPR). The system aims to reliably place an airway tube for ventilation, synchronize air delivery with chest compressions, and enable cardiac defibrillation at lower voltages through an electrode...
The National Science Foundation (NSF) awarded Compact Medical Inc., a for-profit medical device manufacturer, a $999,931 Cooperative Agreement under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program. The funding supports the development and testing of a novel, adjustable bag-valve-mask (BVM) resuscitator device that allows emergency providers to deliver customized air volumes and pressures based on patient body size. This advanced resuscitator aims to address issues with...
Compact Medical Inc. received a $255,925 Small Business Innovation Research Phase I Project Grant from the National Science Foundation to develop a novel respiratory bag-valve-mask resuscitator. The grant was awarded on August 15, 2021 under the NSF's Engineering program (CFDA #47.041) and will support product development activities through February 28, 2022. The Engineering program seeks to foster innovation in engineering research and education to improve quality of life and economic strength....
This Project Grant award from the National Science Foundation (CFDA 47.084 - NSF Technology, Innovation, and Partnerships program) provides $274,274 to X-Cor Therapeutics Inc., a minority-owned small disadvantaged business in Washington, DC, to develop a novel respiratory dialysis system for treating chronic obstructive pulmonary disease (COPD) patients. The project aims to optimize a prototype that can efficiently remove excess carbon dioxide from the blood of COPD patients, with the goal of...
This Project Grant award from the National Science Foundation (NSF) under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program provides $274,841 to XN Health Inc. to develop a novel transtracheal phrenic nerve stimulation device. The device aims to reduce injury rates caused by mechanical ventilation by stimulating the phrenic nerves to induce diaphragmatic contractions, thereby increasing lung inflation and supporting protective ventilation for critically ill patients. The...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $752,495 to the University of Connecticut to develop a deep learning-based method for removing cardiopulmonary resuscitation (CPR) artifacts from electrocardiogram (ECG) signals. The goal is to enable continuous CPR delivery during automated external defibrillator (AED) use, while maintaining accurate cardiac rhythm analysis and shock...
The National Science Foundation (NSF) awarded a Project Grant under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program to Resilient Lifescience, Inc. for the development and validation of a novel wearable medical device to detect and treat opioid overdose. The $274,964 award, effective March 15, 2024 through December 31, 2024, will fund the development of two key components: 1) a self-contained, patch-based drug delivery platform capable of reliably delivering multiple...
The National Science Foundation (NSF) awarded a $275,000 Phase I Small Business Innovation Research (SBIR) grant under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program to KAI TECH LLC. The funding supports the development of an advanced software system called ECG-AID for automated electrocardiogram (ECG) analysis and interpretation. The ECG-AID prototype integrates a comprehensive ECG database, Z-score-based assessments, and machine-learning techniques to enhance the...
RCE Technologies, Inc. was awarded a $255,892 Small Business Innovation Research Phase I Project Grant from the National Science Foundation's Technology, Innovation, and Partnerships program to develop a proof-of-concept machine learning-based diagnostic system for detecting myocardial infarction and ischemia in real-time. The system aims to provide point-of-care clinical classification for heart attack cases using a novel, portable device integrating the awardee's proprietary external...

The National Science Foundation (NSF) awarded a $1,249,999 Cooperative Agreement under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program to CPR Therapeutics Inc. in Putney, VT. The award, with a performance period from July 2025 to June 2027, supports the development of a novel integrated system to improve survival rates and long-term outcomes for patients experiencing cardiac arrest. The project aims to create a fully automated cardiopulmonary resuscitation (CPR) system that combines precision-controlled chest compressions, optimized electrical countershock, and real-time physiological feedback to dynamically adjust treatment and restore circulation. This effort builds on the company's prior SBIR Phase I award and early-stage prototype, and will involve further product technology development, biomonitoring and defibrillation integration, safety testing, interface development, and preclinical validation in an animal model to prepare the product for eventual clinical trials and regulatory approval.

Generated 8/5/25, 5:38 AM